94.92 USD
↘ 3.74 (3.79%)AT CLOSE (11:59 AM EDT)
Guardant Health, Inc. Common Stock
GHNASDAQ • USD
93.20
↘ 1.72 (1.81%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
93.20
↘ 1.72 (1.81%)
Market: CLOSED
Open?$97.31
High?$98.00
Low?$92.50
Prev. Close?$98.66
Volume?1.8M
Avg. Volume?2.1M
VWAP?$94.57
Rel. Volume?0.84x
Bid / Ask
Bid?$81.07 × 100
Ask?$108.00 × 100
Spread?$26.93
Midpoint?$94.54
Valuation & Ratios
Market Cap?12.6B
Shares Out?132.6M
Float?126.2M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?-69.51
EPS?-$3.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Themes
Employees
2.5K
Market Cap
12.6B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2018-10-04
Address
3100 HANOVER STREET
PALO ALTO, CA 94304
Phone: 855-698-8887
PALO ALTO, CA 94304
Phone: 855-698-8887
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.68Strong
Quick Ratio?4.39Strong
Cash Ratio?3.39Strong
Debt/Equity?-8.30Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-69.51CHEAP▾
P/S?11.65HIGH▾
P/FCF?N/A▾
EV/EBITDA?-32.1CHEAP▾
EV/Sales?12.13HIGH▾
Returns & Efficiency
ROE?239.2%STRONG▾
ROA?-22.6%WEAK▾
Cash Flow & Enterprise
FCF?$-237121000
Enterprise Value?$13.1B
Fundamentals ratios updated end of day